Managing hypertension in adults aged 60 and older is essential to reducing health risks like stroke and heart disease. In January 2017, the Annals of Internal Medicine outlined key blood pressure (BP) management recommendations.
- First, clinicians should treat adults 60 and older with systolic BP (sBP) persistently ≥150 mmHg to reduce mortality, strokes, and cardiac events. The goal is to lower sBP to <150 mmHg (strong recommendation, high-quality evidence).
- Second, patients with a history of stroke or transient ischemic attack may benefit from more intensive treatment. Clinicians should aim for an sBP <140 mmHg to reduce recurrent stroke risks.
- Third, for high cardiovascular risk patients, clinicians may target sBP <140 mmHg. This individualized approach balances stroke and cardiac risk reduction against potential harms.
- Periodic discussions between clinicians and patients should guide treatment goals, weighing benefits and risks.
Hypertension affects 65% of U.S. adults aged 60 and older, contributing significantly to healthcare costs. Proper BP management lowers risks of cardiovascular, kidney, and cerebrovascular diseases.
Treatments include lifestyle changes and medications like ACE inhibitors, ARBs, and beta-blockers. However, deciding BP targets in older adults can be challenging due to limited evidence and individual variability.
Elderly patients with multiple conditions or frailty face unique risks. Aggressive treatment may increase syncope or hypotension without clear long-term benefits. These patients often take multiple medications, complicating care and increasing risks of interactions.
Trials frequently excluded frail or cognitively impaired adults, making evidence on aggressive treatment limited for these groups. Results from studies like SPRINT and ACCORD suggest stricter BP targets may benefit non-diabetic populations most. Ultimately, specialists should personalize hypertension management, considering comorbidities, patient preferences, and overall health.
